share_log

Guggenheim Reiterates Buy on Immunocore Hldgs, Maintains $92 Price Target

Moomoo 24/7 ·  Apr 23 12:57

Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment